{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:23:50Z","timestamp":1779344630237,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1006\/clin.1997.4409","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"244-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["TGF-\u03b2: A Critical Modulator of Immune Cell Function"],"prefix":"10.1006","volume":"84","author":[{"given":"John J.","family":"Letterio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita B.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1997.4409_II974409C1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jlb.55.3.401","article-title":"Transforming growth factor-beta: a matter of life and death","volume":"55","author":"McCartney-Francis","year":"1994","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clin.1997.4409_II974409C2","series-title":"Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors","article-title":"The transforming growth factors-\u03b2","author":"Roberts","year":"1990"},{"key":"10.1006\/clin.1997.4409_II974409C3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977199309029129","article-title":"Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta)","volume":"8","author":"Roberts","year":"1993","journal-title":"Growth Factors"},{"key":"10.1006\/clin.1997.4409_II974409C4","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ki.1997.188","article-title":"Latent transforming growth factor-beta: Structural features and mechanisms of activation","volume":"51","author":"Munger","year":"1997","journal-title":"Kidney Int."},{"key":"10.1006\/clin.1997.4409_II974409C5","first-page":"351","article-title":"Latency and activation in the control of TGF-\u03b2","volume":"1","author":"Barcellos-Hoff","year":"1997","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1006\/clin.1997.4409_II974409C6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1083\/jcb.136.5.1151","article-title":"Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta","volume":"136","author":"Nunes","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1006\/clin.1997.4409_II974409C7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI114998","article-title":"An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice","volume":"87","author":"LaMarre","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4409_II974409C8","first-page":"1077","article-title":"Redox-mediated activation of latent transforming growth factor-beta 1","volume":"10","author":"Barcellos-Hoff","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1006\/clin.1997.4409_II974409C9","doi-asserted-by":"crossref","first-page":"26775","DOI":"10.1016\/S0021-9258(18)47086-X","article-title":"Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system","volume":"269","author":"Schultz-Cherry","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/clin.1997.4409_II974409C10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.180.5.1693","article-title":"Spontaneous elaboration of transforming growth factor-beta suppresses host defense against bacterial infection in autoimmune MRL\/lpr mice","volume":"180","author":"Lowrance","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4409_II974409C11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.178.3.841","article-title":"A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor-beta and suppresses cytolytic T cell responses to unrelated alloantigens","volume":"178","author":"Stach","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4409_II974409C12","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.181.5.1875","article-title":"Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor-beta and suppress cytotoxic T lymphocyte responses","volume":"181","author":"Rowley","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4409_II974409C13","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1172\/JCI119068","article-title":"Intracellular demonstration of active TGF-beta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGF-beta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection","volume":"98","author":"Caver","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4409_II974409C14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02253095","article-title":"Transforming growth factor-\u03b2 receptors: Role in physiology and disease","volume":"3","author":"Kim","year":"1996","journal-title":"J. Biomed. Sci."},{"key":"10.1006\/clin.1997.4409_II974409C15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1359-6101(96)00042-1","article-title":"Signal transduction by members of the transforming growth factor-beta superfamily","volume":"7","author":"Attisano","year":"1996","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1006\/clin.1997.4409_II974409C16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/383832a0","article-title":"Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways","volume":"383","author":"Lagna","year":"1996","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4409_II974409C17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/383691a0","article-title":"A transcriptional partner for MAD proteins in TGF-beta signalling","volume":"383","author":"Chen","year":"1996","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4409_II974409C18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1749-6632.1993.tb35911.x","article-title":"Pleiotropic effects of transforming growth factor-beta on cells of the immune system","volume":"685","author":"Ruscetti","year":"1993","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/clin.1997.4409_II974409C19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.157.4.1499","article-title":"TGF-beta 1 promotes in vitro development of dendritic cells from CD34+","volume":"157","author":"Strobl","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.4049\/jimmunol.158.4.1591","article-title":"TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis","volume":"158","author":"Riedl","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C21","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1084\/jem.184.6.2417","article-title":"A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells","volume":"184","author":"Borkowski","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4409_II974409C22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4409_II974409C23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor-beta 1 null mutation in mice causes excessive inflammatory response and early death","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4409_II974409C24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI119567","article-title":"A role for TGF-\u03b21 in Langerhans cell biology: Further characterization of the epidermal Langerhans cell defect in TGF-\u03b21 null mice","author":"Borkowski","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4409_II974409C25","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.179.5.1495","article-title":"Early progression of thymocytes along the CD4\/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor-beta","volume":"179","author":"Takahama","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4409_II974409C26","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.154.11.5789","article-title":"Influence of TGF-beta on murine thymocyte development in fetal thymus organ culture","volume":"154","author":"Plum","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C27","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood.V85.12.3594.bloodjournal85123594","article-title":"Early human thymocyte proliferation is regulated by an externally controlled autocrine transforming growth factor-beta 1 mechanism","volume":"85","author":"Mossalayi","year":"1995","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4409_II974409C28","series-title":"Molecular Biology of Hematopoiesis","first-page":"749","article-title":"TGF-\u03b21 Knockout mice: Immune dysregulation and pathology","author":"Kulkarni","year":"1994"},{"key":"10.1006\/clin.1997.4409_II974409C29","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.158.11.5527","article-title":"Upregulation of cytokine mRNA, adhesion molecule proteins and MHC class II proteins in salivary glands of TGF-\u03b21 knockout mice: MHC class II is a factor in the pathogenesis of TGF-\u03b21 knockout mice","volume":"158","author":"Nakabayashi","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C30","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.4049\/jimmunol.155.6.3205","article-title":"SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice","volume":"155","author":"Dang","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C31","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.180.5.1587","article-title":"Transforming growth factor beta: The good, the bad, and the ugly","volume":"180","author":"Wahl","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4409_II974409C32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1997.4409_II974409C33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/334260a0","article-title":"Deactivation of macrophages by transforming growth factor-beta","volume":"334","author":"Tsunawaki","year":"1988","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4409_II974409C34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(95)90316-X","article-title":"Trypanosome invasion of mammalian cells requires activation of the TGF-beta signaling pathway","volume":"82","author":"Ming","year":"1995","journal-title":"Cell"},{"key":"10.1006\/clin.1997.4409_II974409C35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.1636092","article-title":"Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism","volume":"257","author":"Barral-Netto","year":"1992","journal-title":"Science"},{"key":"10.1006\/clin.1997.4409_II974409C36","first-page":"991","article-title":"Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease","volume":"74","author":"Kopp","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1006\/clin.1997.4409_II974409C37","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.4049\/jimmunol.146.9.3012","article-title":"Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1","volume":"146","author":"Racke","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/intimm\/4.5.615","article-title":"Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis","volume":"4","author":"Racke","year":"1992","journal-title":"Int. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-5728(93)90247-V","article-title":"Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2","volume":"46","author":"Racke","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1006\/clin.1997.4409_II974409C40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/cimm.1994.1240","article-title":"Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice","volume":"157","author":"Santos","year":"1994","journal-title":"Cell Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1073\/pnas.89.1.421","article-title":"Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor-beta after antigen-specific triggering","volume":"89","author":"Miller","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4409_II974409C42","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7520605","article-title":"Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis","volume":"265","author":"Chen","year":"1994","journal-title":"Science"},{"key":"10.1006\/clin.1997.4409_II974409C43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4049\/jimmunol.155.2.910","article-title":"Induction of oral tolerance to myelin basic protein in CD8-depleted mice: Both CD4++","volume":"155","author":"Chen","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0167-5699(97)01000-1","article-title":"Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation","volume":"18","author":"Strober","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1997.4409_II974409C45","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.157.6.2348","article-title":"High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis","volume":"157","author":"Marth","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C46","first-page":"217","article-title":"Suppression of carcinogenesis: A role for TGF-beta and related molecules in prevention of cancer","volume":"51","author":"Wakefield","year":"1990","journal-title":"Immunol. Ser."},{"key":"10.1006\/clin.1997.4409_II974409C47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/1359-6101(96)00001-9","article-title":"Tumor suppressor activity of the TGF-beta pathway in human cancers","volume":"7","author":"Markowitz","year":"1996","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1006\/clin.1997.4409_II974409C48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4,","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"10.1006\/clin.1997.4409_II974409C49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)80128-2","article-title":"MADR2 maps to 18q21 and encodes a TGF-\u03b2-regulated MAD-related protein that is functionally mutated in colorectal carcinoma","volume":"86","author":"Eppert","year":"1996","journal-title":"Cell"},{"key":"10.1006\/clin.1997.4409_II974409C50","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.7761852","article-title":"Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability","volume":"268","author":"Markowitz","year":"1995","journal-title":"Science"},{"key":"10.1006\/clin.1997.4409_II974409C51","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1128\/MCB.16.7.3480","article-title":"A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma","volume":"16","author":"Knaus","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1006\/clin.1997.4409_II974409C52","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1073\/pnas.91.13.6002","article-title":"Loss of receptors for transforming growth factor beta in human T-cell malignancies","volume":"91","author":"Kadin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4409_II974409C53","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/16.10.2621","article-title":"Expression of a dominant-negative mutant TGF-\u03b2 type II receptor in transgenic mice reveals essential roles for TGF-\u03b2 in regulation of growth and differentiation in the exocrine pancreas","volume":"16","author":"B\u00f6ttinger","year":"1997","journal-title":"EMBO J."},{"key":"10.1006\/clin.1997.4409_II974409C54","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.146.3.1077","article-title":"Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state","volume":"146","author":"Tada","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C55","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1073\/pnas.87.4.1486","article-title":"A highly immunogenic tumor transfected with a murine transforming growth factor type-beta 1 cDNA escapes immune surveillance","volume":"87","author":"Torre-Amione","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4409_II974409C56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01533512","article-title":"Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy","volume":"38","author":"Weiskirch","year":"1994","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/clin.1997.4409_II974409C57","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.93.7.2909","article-title":"Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy","volume":"93","author":"Fakhrai","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4409_II974409C58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002371-199605000-00001","article-title":"Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor beta antibody and interleukin-2","volume":"19","author":"Wojtowicz-Praga","year":"1996","journal-title":"J. Immunother. Emphasis Tumor Immunol."},{"key":"10.1006\/clin.1997.4409_II974409C59","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1172\/JCI116871","volume":"92","author":"Arteaga","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4409_II974409C60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF01517218","article-title":"Anti-(transforming growth factor-beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu\/nu mice","volume":"41","author":"Hoefer","year":"1995","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/clin.1997.4409_II974409C61","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1089\/hum.1996.7.16-1981","article-title":"Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity","volume":"7","author":"Qin","year":"1996","journal-title":"Hum. Gene Ther."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:11:04Z","timestamp":1758762664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122997944093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["S0090122997944093"],"URL":"https:\/\/doi.org\/10.1006\/clin.1997.4409","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1997,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF-\u03b2: A Critical Modulator of Immune Cell Function","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1997.4409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997  Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}